+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Aptamers Market by Type, Technology, Application, End-User - Global Forecast to 2030- Product Image
Aptamers Market by Type, Technology, Application, End-User - Global Forecast to 2030- Product Image
Sale

Aptamers Market by Type, Technology, Application, End-User - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4904654
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Aptamers Market is advancing into a pivotal phase, characterized by innovations in molecular recognition technologies and rapidly expanding applications across healthcare, environmental monitoring, and therapeutic development. Senior leaders seeking actionable insight will benefit from a comprehensive understanding of emerging trends, competitive drivers, and region-specific opportunities shaping this dynamic sector.

Aptamers Market Snapshot

The global aptamers market grew from USD 254.35 million in 2024 to USD 285.51 million in 2025, with a projected compound annual growth rate (CAGR) of 12.43% to reach USD 513.77 million by 2030. This robust momentum is driven by technological developments, diversified application areas, and strategic industry initiatives. Market expansion is evident across diagnostics, therapeutics, and specialized research, propelled by enhanced specificity, flexibility, and adoption of advanced platforms.

Scope & Segmentation of the Aptamers Market

This report delivers a thorough evaluation of the aptamers market, dissecting it across multiple axes to help leaders identify high-value opportunities and risks.

  • Type: Nucleic Acid Aptamers, including DNA Aptamers and RNA Aptamers; Peptide Aptamers.
  • Technology: Non-SELEX-Based Technologies; SELEX Technology, which encompasses Capillary Electrophoresis (CE)-SELEX, Capture-SELEX, Cell-SELEX, Graphene Oxide (GO)-SELEX, Microfluidic SELEX, and Standard SELEX.
  • Application: Clinical Diagnostics (Cardiovascular & Metabolic Disease Diagnostics, Genetic & Rare Disease Screening, Infectious Disease Diagnostics, Neurological Disorder Diagnostics, Oncology Diagnostics); Food & Environmental Safety (Agricultural Testing, Environmental Monitoring, Food Safety Testing); Therapeutics & Drug Development (Cardiovascular Diseases, Infectious Diseases, Neurological Disorders, Oncology, Rare & Genetic Disorders).
  • End-User: Academic & Research Institutions, Hospital & Clinics, Pharmaceutical & Biotechnology Companies.
  • Region: Americas (including United States, Canada, Mexico, Brazil, Argentina and select U.S. states), Europe, Middle East & Africa (with a wide coverage from United Kingdom and Germany to South Africa and Saudi Arabia), Asia-Pacific (spanning China, India, Japan, Australia, and several others).
  • Key Companies: 2bind GmbH, Agilent Technologies, Aptadel Therapeutics, Aptagen, Aptamer Group PLC, AptaTargets, Astellas Pharma, Base Pair Biotechnologies, Bio-Techne, Biogenes Technologies, Biotage, Creative Biogene, Drive Therapeutics, F. Hoffmann-La Roche, Kaneka Eurogentec, LC Sciences, NEC Corporation, NeoVentures Biotechnology, SomaLogic, TAGCyx Biotechnologies, Veraptus, Zentek, among others.

Key Takeaways for Senior Decision-Makers

  • Technological refinement, including rapid high-throughput sequencing and microfluidic platforms, is accelerating discovery timelines and reducing resource expenditure across development stages.
  • Segmental analysis indicates nucleic acid aptamers currently dominate, with peptides gaining application in complex target engagement scenarios, supporting differentiated product strategies for industry stakeholders.
  • Applications continue to expand beyond clinical diagnostics into rare disease screening, oncology biomarker detection, and food and environmental monitoring, driven by the need for high specificity and operational adaptability.
  • Integrated partnerships between technology providers, research organizations, and commercial end-users are facilitating the move from proof-of-concept to scalable commercialization in diverse regions.
  • Regionally, the Americas lead in early-stage deployment and innovation, while Asia-Pacific establishes itself as a manufacturing and application growth center, and EMEA advances precision medicine and public health solutions.
  • Competitive dynamics are shaped by established conglomerates investing in aptamer platforms, alongside agile startups advancing proprietary selection chemistries and AI-driven optimization methodologies.

Impact of US Tariffs on Aptamer Supply Chains

The introduction of new US tariffs on critical reagents and laboratory instrumentation is prompting companies to adjust by pursuing supplier diversification and exploring on-site synthesis capabilities. These strategies are balancing cost inflation while maintaining supply chain continuity. Industry coalitions are actively engaged with policy advocacy seeking tariff exemptions on research-critical components, which will be integral to future sector competitiveness and pricing stability.

Methodology & Data Sources

This analysis utilizes a multi-layered research framework, combining structured interviews with industry experts and executives, a review of scientific publications and regulatory filings, and verification through proprietary databases. Quantitative findings are validated through triangulation, while qualitative assessments integrate scenario planning and resilience analysis.

Why This Report Matters

  • Supports executive decision-making by clarifying which technologies, segments, and regions are most likely to yield sustainable growth or face disruption.
  • Offers insights into supplier strategies, innovation drivers, and partnership opportunities that help de-risk expansion, streamline investment, and accelerate time to market.
  • Delivers practical guidance for navigating evolving supply dynamics, regulatory hurdles, and the competitive environment unique to aptamers.

Conclusion

The aptamers market is evolving rapidly with rising adoption across scientific and commercial domains. Leaders who prioritize innovation, resilient supply strategies, and smart market entry will capitalize on emerging opportunities and strengthen their market position.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Aptamers Market, by Type
8.1. Introduction
8.2. Nucleic Acid Aptamers
8.2.1. DNA Aptamers
8.2.2. RNA Aptamers
8.3. Peptide Aptamers
9. Aptamers Market, by Technology
9.1. Introduction
9.2. Non-SELEX-Based Technologies
9.3. SELEX Technology
9.3.1. Capillary Electrophoresis (CE)-SELEX
9.3.2. Capture-SELEX
9.3.3. Cell-SELEX
9.3.4. Graphene Oxide (GO)-SELEX
9.3.5. Microfluidic SELEX
9.3.6. Standard SELEX
10. Aptamers Market, by Application
10.1. Introduction
10.2. Clinical Diagnostics
10.2.1. Cardiovascular & Metabolic Disease Diagnostics
10.2.2. Genetic & Rare Disease Screening
10.2.3. Infectious Disease Diagnostics
10.2.4. Neurological Disorder Diagnostics
10.2.5. Oncology Diagnostics
10.3. Food & Environmental Safety
10.3.1. Agricultural Testing
10.3.2. Environmental Monitoring
10.3.3. Food Safety Testing
10.4. Therapeutics & Drug Development
10.4.1. Cardiovascular Diseases
10.4.2. Infectious Diseases
10.4.3. Neurological Disorders
10.4.4. Oncology
10.4.5. Rare & Genetic Disorders
11. Aptamers Market, by End-User
11.1. Introduction
11.2. Academic & Research Institutions
11.3. Hospital & Clinics
11.4. Pharmaceutical & Biotechnology Companies
12. Americas Aptamers Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Aptamers Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Aptamers Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. 2bind GmbH
15.3.2. Agilent Technologies, Inc.
15.3.3. Aptadel Therapeutics SL
15.3.4. Aptagen, LLC
15.3.5. AptaMatrix, Inc.
15.3.6. Aptamer Group PLC
15.3.7. AptaTargets SL
15.3.8. AptusBiotech
15.3.9. Astellas Pharma Inc.
15.3.10. Base Pair Biotechnologies, Inc.
15.3.11. Basking Biosciences
15.3.12. Bio-Techne Corporation
15.3.13. Biogenes Technologies Sdn. Bhd.
15.3.14. Biotage
15.3.15. Cage Bio, Inc.
15.3.16. Creative Biogene
15.3.17. Creative Biolabs
15.3.18. Drive Therapeutics, LLC
15.3.19. F. Hoffmann-La Roche AG
15.3.20. Kaneka Eurogentec S.A.
15.3.21. LC Sciences
15.3.22. NEC Corporation
15.3.23. NeoVentures Biotechnology Inc.
15.3.24. NOVAPTECH, S.A.S.
15.3.25. Profacgen
15.3.26. SomaLogic, Inc.
15.3.27. TAGCyx Biotechnologies, Inc.
15.3.28. Veraptus
15.3.29. Vivonics Inc.
15.3.30. Zentek Ltd.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. APTAMERS MARKET MULTI-CURRENCY
FIGURE 2. APTAMERS MARKET MULTI-LANGUAGE
FIGURE 3. APTAMERS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL APTAMERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL APTAMERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL APTAMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL APTAMERS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL APTAMERS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL APTAMERS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL APTAMERS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL APTAMERS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL APTAMERS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL APTAMERS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL APTAMERS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS APTAMERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS APTAMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES APTAMERS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES APTAMERS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC APTAMERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC APTAMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. APTAMERS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. APTAMERS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. APTAMERS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL APTAMERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL APTAMERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL APTAMERS MARKET SIZE, BY DNA APTAMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL APTAMERS MARKET SIZE, BY RNA APTAMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL APTAMERS MARKET SIZE, BY PEPTIDE APTAMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL APTAMERS MARKET SIZE, BY NON-SELEX-BASED TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL APTAMERS MARKET SIZE, BY CAPILLARY ELECTROPHORESIS (CE)-SELEX, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL APTAMERS MARKET SIZE, BY CAPTURE-SELEX, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL APTAMERS MARKET SIZE, BY CELL-SELEX, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL APTAMERS MARKET SIZE, BY GRAPHENE OXIDE (GO)-SELEX, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL APTAMERS MARKET SIZE, BY MICROFLUIDIC SELEX, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL APTAMERS MARKET SIZE, BY STANDARD SELEX, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL APTAMERS MARKET SIZE, BY CARDIOVASCULAR & METABOLIC DISEASE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL APTAMERS MARKET SIZE, BY GENETIC & RARE DISEASE SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL APTAMERS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL APTAMERS MARKET SIZE, BY NEUROLOGICAL DISORDER DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL APTAMERS MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL APTAMERS MARKET SIZE, BY AGRICULTURAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL APTAMERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL APTAMERS MARKET SIZE, BY FOOD SAFETY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL APTAMERS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL APTAMERS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL APTAMERS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL APTAMERS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL APTAMERS MARKET SIZE, BY RARE & GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL APTAMERS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL APTAMERS MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL APTAMERS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES APTAMERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 66. CANADA APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. CANADA APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
TABLE 68. CANADA APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 69. CANADA APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 70. CANADA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. CANADA APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 72. CANADA APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD MILLION)
TABLE 73. CANADA APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 74. CANADA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. MEXICO APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. MEXICO APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
TABLE 77. MEXICO APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 78. MEXICO APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 79. MEXICO APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. MEXICO APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 81. MEXICO APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD MILLION)
TABLE 82. MEXICO APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 83. MEXICO APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. GERMANY APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. GERMANY APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
TABLE 123. GERMANY APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 124. GERMANY APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 125. GERMANY APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. GERMANY APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 127. GERMANY APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD MILLION)
TABLE 128. GERMANY APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 129. GERMANY APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. FRANCE APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 131. FRANCE APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
TABLE 132. FRANCE APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. FRANCE APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 134. FRANCE APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. FRANCE APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 136. FRANCE APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD MILLION)
TABLE 137. FRANCE APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 138. FRANCE APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. RUSSIA APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. RUSSIA APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
TABLE 141. RUSSIA APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 142. RUSSIA APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 143. RUSSIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. RUSSIA APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 145. RUSSIA APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD MILLION)
TABLE 146. RUSSIA APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 147. RUSSIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. ITALY APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 149. ITALY APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
TABLE 150. ITALY APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 151. ITALY APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 152. ITALY APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. ITALY APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 154. ITALY APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD MILLION)
TABLE 155. ITALY APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 156. ITALY APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 157. SPAIN APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 158. SPAIN APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
TABLE 159. SPAIN APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 160. SPAIN APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 161. SPAIN APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. SPAIN APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 163. SPAIN APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD MILLION)
TABLE 164. SPAIN APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 165. SPAIN APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 166. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 167. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
TABLE 168. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 169. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 170. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 172. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD MILLION)
TABLE 173. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 174. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 175. SAUDI ARABIA APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 176. SAUDI ARABIA APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
TABLE 177. SAUDI ARABIA APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 178. SAUDI ARABIA APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 179. SAUDI ARABIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. SAUDI ARABIA APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 181. SAUDI ARABIA APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD MILLION)
TABLE 182. SAUDI ARABIA APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 183. SAUDI ARABIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 184. SOUTH AFRICA APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 185. SOUTH AFRICA APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
TABLE 186. SOUTH AFRICA APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 187. SOUTH AFRICA APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 188. SOUTH AFRICA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. SOUTH AFRICA APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 190. SOUTH AFRICA APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD MILLION)
TABLE 191. SOUTH AFRICA APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 192. SOUTH AFRICA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 193. DENMARK APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 194. DENMARK APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
TABLE 195. DENMARK APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 196. DENMARK APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 197. DENMARK APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. DENMARK APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 199. DENMARK APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD MILLION)
TABLE 200. DENMARK APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 201. DENMARK APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 206. NETHERLANDS APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. NETHERLANDS APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 208. NETHERLANDS APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD MILLION)
TABLE 209. NETHERLANDS APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 210. NETHERLANDS APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 211. QATAR APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 212. QATAR APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
TABLE 213. QATAR APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 214. QATAR APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 215. QATAR APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. QATAR APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 217. QATAR APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD MILLION)
TABLE 218. QATAR APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 219. QATAR APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 220. FINLAND APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 221. FINLAND APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
TABLE 222. FINLAND APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 223. FINLAND APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 224. FINLAND APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. FINLAND APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 226. FINLAND APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD MILLION)
TABLE 227. FINLAND APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 228. FINLAND APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 229. SWEDEN APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 230. SWEDEN APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
TABLE 231. SWEDEN APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 232. SWEDEN APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 233. SWEDEN APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. SWEDEN APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 235. SWEDEN APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD MILLION)
TABLE 236. SWEDEN APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 237. SWEDEN APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. NIGERIA APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 244. NIGERIA APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD MILLION)
TABLE 245. NIGERIA APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 246. NIGERIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 247. EGYPT APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 248. EGYPT APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
TABLE 249. EGYPT APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 250. EGYPT APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 251. EGYPT APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 252. EGYPT APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 253. EGYPT APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD MILLION)
TABLE 254. EGYPT APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 255. EGYPT APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 256. TURKEY APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 257. TURKEY APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
TABLE 258. TURKEY APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 259. TURKEY APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 260. TURKEY APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. TURKEY APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 262. TURKEY APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD MILLION)
TABLE 263. TURKEY APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 264. TURKEY APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 265. ISRAEL APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 266. ISRAEL APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
TABLE 267. ISRAEL APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 268. ISRAEL APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 269. ISRAEL APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 270. ISRAEL APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 271. ISRAEL APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD MILLION)
TABLE 272. ISRAEL APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 273. ISRAEL APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 274. NORWAY APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 275. NORWAY APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
TABLE 276. NORWAY APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 277. NORWAY APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 278. NORWAY APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. NORWAY APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 280. NORWAY APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD MILLION)
TABLE 281. NORWAY APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 282. NORWAY APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 283. POLAND APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 284. POLAND APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
TABLE 285. POLAND APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 286. POLAND APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 287. POLAND APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 288. POLAND APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 289. POLAND APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD MILLION)
TABLE 290. POLAND APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 291. POLAND APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 292. SWITZERLAND APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 293. SWITZERLAND APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
TABLE 294. SWITZERLAND APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 295. SWITZERLAND APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 296. SWITZERLAND APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 297. SWITZERLAND APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 298. SWITZERLAND APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD MILLION)
TABLE 299. SWITZERLAND APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 301. ASIA-PACIFIC APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 302. ASIA-PACIFIC APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
TABLE 303. ASIA-PACIFIC APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 304. ASIA-PACIFIC APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 305. ASIA-PACIFIC APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 306. ASIA-PACIFIC APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 307. ASIA-PACIFIC APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD MILLION)
TABLE 308. ASIA-PACIFIC APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 309. ASIA-PACIFIC APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 310. ASIA-PACIFIC APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 311. CHINA APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 312. CHINA APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
TABLE 313. CHINA APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 314. CHINA APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 315. CHINA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 316. CHINA APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 317. CHINA APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD MILLION)
TABLE 318. CHINA APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 319. CHINA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 320. INDIA APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 321. INDIA APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
TABLE 322. INDIA APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 323. INDIA APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 324. INDIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 325. INDIA APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 326. INDIA APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD MILLION)
TABLE 327. INDIA APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 328. INDIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 329. JAPAN APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 330. JAPAN APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
TABLE 331. JAPAN APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 332. JAPAN APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 333. JAPAN APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 334. JAPAN APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 335. JAPAN APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD MILLION)
TABLE 336. JAPAN APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 337. JAPAN APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 338. AUSTRALIA APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 339. AUSTRALIA APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
TABLE 340. AUSTRALIA APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 341. AUSTRALIA APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 342. AUSTRALIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 343. AUSTRALIA APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 344. AUSTRALIA APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD MILLION)
TABLE 345. AUSTRALIA APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 346. AUSTRALIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 347. SOUTH KOREA APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 348. SOUTH KOREA APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
TABLE 349. SOUTH KOREA APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 350. SOUTH KOREA APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 351. SOUTH KOREA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 352. SOUTH KOREA APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 353. SOUTH KOREA APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD MILLION)
TABLE 354. SOUTH KOREA APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 355. SOUTH KOREA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 356. INDONESIA APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 357. INDONESIA APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
TABLE 358. INDONESIA APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 359. INDONESIA APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 360. INDONESIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 361. INDONESIA APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 362. INDONESIA APTAMERS MARKET SIZE, BY FOOD & ENVIRONMENTAL SAFETY, 2018-2030 (USD MILLION)
TABLE 363. INDONESIA APTAMERS MARKET SIZE, BY THERAPEUTICS & DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 364. INDONESIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 365. THAILAND APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 366. THAILAND APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
TABLE 367. THAILAND APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 368. THAILAND APTAMERS MARKET SIZE, BY SELEX TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 369. THAILAND APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 370. THAILAND APTAMERS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TA

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Aptamers market report include:
  • 2bind GmbH
  • Agilent Technologies, Inc.
  • Aptadel Therapeutics SL
  • Aptagen, LLC
  • AptaMatrix, Inc.
  • Aptamer Group PLC
  • AptaTargets SL
  • AptusBiotech
  • Astellas Pharma Inc.
  • Base Pair Biotechnologies, Inc.
  • Basking Biosciences
  • Bio-Techne Corporation
  • Biogenes Technologies Sdn. Bhd.
  • Biotage
  • Cage Bio, Inc.
  • Creative Biogene
  • Creative Biolabs
  • Drive Therapeutics, LLC
  • F. Hoffmann-La Roche AG
  • Kaneka Eurogentec S.A.
  • LC Sciences
  • NEC Corporation
  • NeoVentures Biotechnology Inc.
  • NOVAPTECH, S.A.S.
  • Profacgen
  • SomaLogic, Inc.
  • TAGCyx Biotechnologies, Inc.
  • Veraptus
  • Vivonics Inc.
  • Zentek Ltd.

Table Information

Report AttributeDetails
No. of Pages188
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 285.51 Million
Forecasted Market Value ( USD ) by 2030 $ 513.77 Million
Compound Annual Growth Rate12.4%
Regions CoveredGlobal
No. of Companies Mentioned31

Related Topics

Related Reports

Aptamers - Global Strategic Business Report - Product Image

Aptamers - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Aptamers Market Report 2025 - Product Image

Aptamers Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Aptamer Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application - Product Image

Aptamer Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application

  • Report
  • 93 Pages
  • Global
From
Aptamers Market Report by Type, Application, and Region 2024-2032 - Product Image

Aptamers Market Report by Type, Application, and Region 2024-2032

  • Report
  • 147 Pages
  • Global
From
Aptamer Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Aptamer Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From

About the Aptamer Market

The Aptamer market is a subset of the biotechnology industry that focuses on the development and production of aptamers, which are short, single-stranded DNA or RNA molecules that can bind to specific targets. Aptamers are used in a variety of applications, including diagnostics, therapeutics, and research. Aptamers are often used as alternatives to antibodies, as they are more stable, easier to produce, and can be tailored to bind to a wide range of targets. Aptamers are produced through a process called SELEX (Systematic Evolution of Ligands by Exponential Enrichment), which involves iterative cycles of selection and amplification of aptamers that bind to the desired target. This process is often automated, allowing for the rapid production of aptamers. The Aptamer market is growing rapidly, driven by increasing demand for aptamers in research and clinical applications. Companies in the Aptamer market include Aptagen, Aptamer Solutions, Base Pair Biotechnologies, and Aptamer Group. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.